IDT Australia Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IDT.AX research report →
Price Chart
About the company
IDT Australia Limited is an enterprise deeply involved in the entire lifecycle of pharmaceutical products, from initial research and development through to manufacturing and global distribution of both active pharmaceutical ingredients (APIs) and finished dosage forms. The company furnishes comprehensive analytical support, including the establishment of testing methodologies, stability assessments utilizing specialized chambers, and quality control laboratory services for both chemical and microbiological applications. Furthermore, its service offerings span project management, chemical processing, advanced analytical chemistry, pharmacy support, clinical trial packaging, and regulatory compliance assistance, alongside pharmaceutical development expertise across diverse dosage forms.
- CEO
- Mark Simari
- IPO
- 1988
- Employees
- 156
- HQ
- Boronia, VIC, AU
Get TickerSpark's AI analysis on IDT.AX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $19.23M
- P/E
- -7.03
- Fwd P/E
- 3.21
- PEG
- -0.08
- P/S
- 0.94
- P/B
- 1.01
- EV/EBITDA
- -37.06
- Div Yield
- 0.00%
- Gross Margin
- 21.10%
- Op Margin
- -8.09%
- Net Margin
- -13.35%
- ROE
- -13.81%
- ROIC
- -5.48%
Latest fiscal year · YoY change
- Revenue
- $20.36M+3.0%
- Gross Profit
- $4.29M-55.7%
- Op Income
- $-1,646,000
- Net Income
- $-2,717,000+66.3%
- EPS
- $-0.01+64.6%
- OCF Growth
- +117.1%
- FCF Growth
- +96.8%
- 52W High
- $0.07
- 52W Low
- $0.03
- 50D MA
- $0.04
- 200D MA
- $0.04
- Beta
- 0.90
- RSI (14)
- 59
- Avg Volume
- 300.17K
No earnings-call transcripts are available for IDT.AX yet.
- Free Float
- 81.3%
- Shares Outstanding
- 427.26M
- Float Shares
- 347.44M
Our IDT.AX coverage
Recent articles, reports, and earnings notes.
No research on IDT.AX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate IDT.AX report →